Add this event to your calendarOct 9, 201810/09/18Illumina User Group Meeting - New York City
You’re invited to the Illumina User Group Meeting in New York City on
Tuesday, October 9, 2018, 8:00 AM – 5:00 PM, where we will share about
the progress being made using Illumina Next-Generation Sequencing and
Array technology. You’ll hear from researchers like you about the
discoveries they have made with genomic technology and how they
continue to move the needle in our joint quest to unlock the power of
the human genome.
Illumina User Group Meetings provide an invaluable forum to learn
how the latest technology and methods can accelerate your discoveries.
Ami Bhatt, MD, PhD, Assistant Professor of Medicine and of
Jason Buenrostro, PhD, Broad Institute
Fellow of MIT and Harvard, Harvard Society of Fellows, Junior
Fellow, Broad Institute of MIT and Harvard
PhD, Postdoctoral Associate, Molecular & Human Genetics, Aiden
Lab, Baylor College of Medicine
Alison Goate, DPhil,
Professor of Neuroscience; Director of Ronald M. Loeb Center
Shareef Nahas, PhD, FACMG, CGMB Senior Director Clinical
Laboratory Operations, Rady Children’s Institute for Genomic
Matija Snuderl, MD, Assistant Professor, Department
of Pathology; Director, Molecular Pathology, NYU Langone Medical
Center and Medical School
Kathleen C Barnes, PhD, Director,
Colorado Center for Personalized Medicine, Head Division of
Biomedical Informatics & Personalized Medicine, University of
Colorado, Department of Medicine
Aboli Rane, PhD, Sr
Regional Segment Manager, Genetic Disease Research, Illumina,
Maude Champagne, MBA, Commercial Development, Oncology,
Britt Flaherty, PhD, Executive Sequencing
Specialist, Illumina, Inc.
Kevin Taylor, PhD, Sr Manager,
Complex Disease, Illumina, Inc.
Join us for:
Illumina product updates, including the NovaSeq™ system and
our investment in the future of genomics.
New research from
your peers using the latest technology: topics include single cell
sequencing, genome structures, and complex disease research.
Hot topics in precision medicine, including methylation-based
tumor classification, implementation of population screening with
arrays, and critical updates on the microbiome.
Energy Expo to learn about new solutions from Illumina and our
partners, and an opportunity to connect with technical experts or
engage in discussions with your peers.
Who Should Attend:
Illumina User Group Meetings are exclusively for those who own, use,
or have their data generated on Illumina instrumentation. The
presentations will cover a broad range of applications, and are
designed for new or experienced users in the areas of optimization of
the sequencing workflow or bioinformatics.
Add this event to your calendar07/20/18 2 PM (PT)07/20/18Immunotherapy and genomics innovation advance Illumina’s vision for precision oncology
Genomics is facilitating a deeper understanding of cancer biology and
through clinical research, new biomarkers are emerging that pave the
way for next-generation therapeutics to help fight cancer in a more
In this webinar, Sandip Patel, MD will provide a review of biomarker
research and discoveries in the field of Immunotherapy and Garret
Hampton, PhD will discuss Illumina’s vision for Oncology and share how
genomics will enable broader availability of comprehensive tumor
sequencing to explore complex biomarkers and assess tumor mutational burden.
Add this event to your calendar01/30/18 8 AM and 5 PM01/30/18Introducing the iSeq™ 100 Sequencing System—our latest solution for fast and efficient low-throughput sequencing for virtually any lab
Explore our smallest and most cost-effective sequencer ever. Join
Bellal Moghis and Gary Schroth as they introduce our newest
system—iSeq 100. They’ll walk through installation and also review
applications and methods. Find out how you can make the most of your
new lab partner.
Add this event to your calendar01/24/18 10 AM (PT)01/24/18CosmosID Metagenomics for Public Health, Food/Water Safety, and Epidemiology
With the dramatically increasing amount of sequence data generation
and the significant reduction of sequencing costs, rapid, easy, and
accurate data analytics becomes the critical bottleneck in adopting
next-generation sequencing (NGS) in the public health sector. To this
end, CosmosID has developed a cloud-based microbial genomics platform
featuring with world’s largest curated genome databases and scaling
computational power to keep pace with the ever-increasing amount of
data generation. The platform brings together the most comprehensive
and ultrafast “sequence to answer” workflow for easy, accurate, and
highly resolved profiling of cross-disciplinary microbiome data. In
this webinar, various aspects of the platform will be presented with
reference to recent studies on water and wastewater treatment, food
safety, molecular epidemiology, and multi-kingdom microbiome profiling
and characterization. Key technologies that will be showcased include
strain-level metagenomics, metatranscriptomics, metagenomic assembly,
and molecular sub-typing.
Add this event to your calendar01/23/18 8 AM and 5 PM01/23/18AmpliSeq™ for Illumina®—fast, simple, robust targeted library prep chemistry for Illumina sequencing systems
See what happens when a leading library prep is optimized to run on
next-generation sequencing (NGS) systems from Illumina. Join Mitu
Chaudhary and Claire White as they present data to demonstrate the
robust performance of AmpliSeq for Illumina from a wide variety of
Add this event to your calendar12/13/17 10 AM (PT)12/13/17High-volume sequence analysis with BaseSpace Sequence Hub and Edico Genome DRAGEN apps
The latest sequencing technologies enable unprecedented throughput
and redefine limits for many labs. To adapt, these labs must redefine
how they work – by automating tasks to reduce touchpoints and by
simplifying workflows with integration and robust analysis tools. In
this webinar, we describe BaseSpace™ Sequence Hub and how the newest
features support high throughput, high-volume sequencing. We
demonstrate how customers can progress from flowcell loading to
variant analysis with zero touchpoints by using the Whole Genome
Sequencing or Edico Genome DRAGEN apps. Additionally, we describe how
the integration with BaseSpace™ Variant Interpreter enables users to
interpret and generate reports of identified variants.
Add this event to your calendar12/07/17 10 AM (PT)12/07/17Enabling efficient Discovery and Clinical Research in drug response: Application of a targeted Next-Generation Sequencing Assay for Pharmacogenetics
Pharmacogenetic (PGx) testing enables researchers to understand a
person’s genetic propensity for a therapeutic response or an adverse
reaction to particular medications. Recently the NIH’s Precision
Medicine Initiative has begun a nationwide effort to individualize a
subject’s treatment program, while the FDA has already included PGx
information in over one hundred drug labels. Serious drug reaction
events are likely to become more prevalent as more drugs become
available and the number of pharmaceuticals each person is taking
increases. To understand the occurrence of these events, sequencing
genomic regions associated with metabolism of a wide-spectrum of drug
classes can help inform clinical researchers, and better characterize
the frequency of known and novel haplotypes within validated genes
involved in drug metabolism pathways.
presentation, we will describe a method and workflow for targeted
pharmacogenetic gene sequencing using Kailos’ TargetRichTM PGxComplete assay.